Pharmacologic Characterization of Contractile Serotonergic
Receptors in Human Isolated Mesenteric Artery
*Husamettin Gul, *Oguzhan Yildiz, †Abdurrahman Simsek, †Mujdat Balkan, †Nail Ersoz,
†Sadettin Cetiner, *Askin Isimer, and †Dervis Sen
Departments of *Pharmacology and †Surgery, Gu ¨lhane Military Medical Academy, Faculty of Medicine, Etlik,
Ankara, Turkey
Summary: The 5-hydroxytryptamine (5-HT) receptors mediating contraction
in human isolated mesenteric arteries were characterized. Endothelium-
denuded human isolated mesenteric arteries were used. 5-HT induced con-
centration-dependent contractions in mesenteric arteries (E
max
, 127.37 ±
7.61% of 80 mM KCl maximal contraction; pD
2
, 6.73 ± 0.09 [-logEC
50
]).
Sumatriptan, a selective 5-HT
1B/1D
receptor agonist, induced concentration-
dependent contractions in some of the arteries (E
max
, 61.82 ± 10.04%; pD
2
,
6.56 ± 0.21, n 9) but not in the others (E
max
< 5%, n 13), suggesting that
functional 5-HT
1B/1D
receptors exist in some but not in all mesenteric arteries.
GR127935 (a selective 5-HT
1B/1D
receptor antagonist, 3 nM) inhibited suma-
triptan-induced contractions in arteries in which sumatriptan responses were
strong in an insurmountable manner. GR127935 (10 nM) also inhibited 5-HT
responses and shifted the concentration–response curve of 5-HT to the right
significantly (p < 0.05; pD
2
s were 6.54 ± 0.18 and 5.93 ± 0.11 in the presence
of vehicle and GR127935, respectively). Ketanserin (0.01–1 M) competi-
tively antagonized 5-HT responses in human mesenteric arteries: pA
2
value
was 8.40 ± 0.25 (slope of Schild regression, 1.43 ± 0.18; r
2
, 0.98). Tropisetron
(5-HT
3
receptor antagonist) and prazosin (
1
-adrenoceptor antagonist) did not
affect the contractions induced by 5-HT. These results suggest that 5-HT
2A
and 5-HT
1B/1D
receptors, but not 5-HT
3
and
1
-adrenoceptors, are involved in
the 5-HT–induced contractions in human isolated mesenteric arteries. Suma-
triptan-induced and 5-HT
1B/1D
receptor-mediated responses vary greatly
among patients. Key Words: 5-hydroxytryptamine—Characterization—
Sumatriptan—5-HT
1B/1D
receptors—5-HT
2A
receptors—Human mesenteric
artery.
5-Hydroxytryptamine (5-HT, serotonin) has been
shown to be a potent vasoconstrictor of the vasculature
(1,2). The various effects of 5-HT on the central nervous
system and peripheral organs are mediated through acti-
vation of multiple types of receptors (1). Although there
are seven 5-HT receptor families identified so far,
5-HT
2A
and 5-HT
1B/1D
receptor subtypes are almost ex-
clusively responsible for 5-HT–induced vasoconstriction
Received January 29, 2002; accepted July 16, 2002.
Supported by GATA Research and Development Center (1998/28).
Address correspondence and reprint requests to Oguzhan Yildiz at
the Department of Pharmacology, Gulhane Military Medical Academy,
School of Medicine, 06018, Etlik, Ankara, Turkey. E-mail: oyildiz@
gata.edu.tr
Journal of Cardiovascular Pharmacology™
41:307–315 © 2003 Lippincott Williams & Wilkins, Inc., Philadelphia
307